Cargando…
Towards Personalized Medicine in Myasthenia Gravis: Role of Circulating microRNAs miR-30e-5p, miR-150-5p and miR-21-5p
Myasthenia gravis (MG) is an autoimmune neuromuscular disease characterized by fatigable skeletal muscle weakness with a fluctuating unpredictable course. One main concern in MG is the lack of objective biomarkers to guide individualized treatment decisions. Specific circulating serum microRNAs (miR...
Autores principales: | Beretta, Francesca, Huang, Yu-Fang, Punga, Anna Rostedt |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870722/ https://www.ncbi.nlm.nih.gov/pubmed/35203389 http://dx.doi.org/10.3390/cells11040740 |
Ejemplares similares
-
Thymectomy lowers the myasthenia gravis biomarker miR-150-5p
por: Molin, Carl Johan, et al.
Publicado: (2018) -
Circulating miRNAs in myasthenia gravis: miR-150-5p as a new potential biomarker
por: Punga, Tanel, et al.
Publicado: (2014) -
miR‐30e‐5p as predictor of generalization in ocular myasthenia gravis
por: Sabre, Liis, et al.
Publicado: (2019) -
Causes and Consequences of miR-150-5p Dysregulation in Myasthenia Gravis
por: Cron, Mélanie A., et al.
Publicado: (2019) -
Combined detection of miR-21-5p, miR-30a-3p, miR-30a-5p, miR-155-5p, miR-216a and miR-217 for screening of early heart failure diseases
por: Ding, Han, et al.
Publicado: (2020)